logotype
  • About
    • Membership
    • Board & Secretariat
    • Partnership
    • Statutes
  • Position Papers
    • Technical Regulatory Affairs
    • Digital Health
    • Sustainability
    • Innovation
  • Innovation
    • Driving Innovation in Healthcare
    • Resources & Opportunities
    • Participating in IHI
    • Submission FAQ
  • Services
    • Committees and Working groups
    • Sustainability
    • Market Intelligence
  • News
    • Events
    • Publications
    • Press Releases
    • Jobs
  • About
    • Membership
    • Board & Secretariat
    • Partnership
    • Statutes
  • Position Papers
    • Technical Regulatory Affairs
    • Digital Health
    • Sustainability
    • Innovation
  • Innovation
    • Driving Innovation in Healthcare
    • Resources & Opportunities
    • Participating in IHI
    • Submission FAQ
  • Services
    • Committees and Working groups
    • Sustainability
    • Market Intelligence
  • News
    • Events
    • Publications
    • Press Releases
    • Jobs
logotype
logotype
  • About
    • Membership
    • Board & Secretariat
    • Partnership
    • Statutes
  • Position Papers
    • Technical Regulatory Affairs
    • Digital Health
    • Sustainability
    • Innovation
  • Innovation
    • Driving Innovation in Healthcare
    • Resources & Opportunities
    • Participating in IHI
    • Submission FAQ
  • Services
    • Committees and Working groups
    • Sustainability
    • Market Intelligence
  • News
    • Events
    • Publications
    • Press Releases
    • Jobs
Targeted revision of EU MDR Rule 11 for medical device software
HomePositionsTargeted revision of EU MDR Rule 11 for medical device software
Positions
Home » Position Papers » Technical Regulatory Affairs » Targeted revision of EU MDR Rule 11 for medical device software
Technical Regulatory Affairs

Targeted revision of EU MDR Rule 11 for medical device software

  • Download this position paper
DOWNLOAD THIS POSITION PAPER

MDR Classification Rule 11 on software has been revised in response to numerous implementation challenges over the past years. In December 2025, the European Commission proposed a revised version of Rule 11, however, several key terms (inform, drive, risk of causing) remain too open to interpretation, creating legal uncertainty and reducing predictability for both manufacturers and authorities. COCIR therefore proposes alternative wording that addresses these challenges, considering international convergence and following a risk-based approach, while supporting the Commission’s objective of simplification without compromising patient safety.

COCIR recommends a simplified rule that preserves the healthcare-situation reflected in the Commission’s proposal but removes the concept of “confers a clinical benefit,” and the distinction between “inform/drive clinical management” distinction and adds the dimension of “healthcare professional oversight’’. This approach is intended to make the rule more operational and reduce possible divergent interpretations.

DOWNLOAD THIS PAPER
Explore More Papers

All Position Papers

Technical Regulatory Affairs

Digital Health

Sustainabilty

Innovation

All Positions

Technical Regulatory Affairs

Digital Health

Sustainabilty

Innovation

All Positions

Technical Regulatory Affairs

Digital Health

Sustainabilty

Innovation

Not a member yet?

Join us

FIND OUT MORE
COCIR

Silversquare Europe
Square de Meeûs 35
1000 Brussels

+32 (0)2 895 36 01
[email protected]
Get to know
About
Position Papers
Innovation
Services
Stay tuned
News
Events
Publications
Follow
Linkedin-inYoutube
Subscribe

    No spam, notifications only about new products, updates.

    Copyright © 2025 COCIR. All Rights Reserved

    Privacy Policy

    Disclaimer
    Sitemap